Full Name | Dr Randy Gilliland |
---|---|
Gender | Male |
Speciality | Clinical Psychologist |
Experience | 9 Years |
Location | 525 W 200 N, Mona, Utah |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1629431788 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | 9655966-2501 (Utah) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Intermountain Healthcare Services, Inc | 1850209420 | 3063 |
News Archive
"First patient in" is the call from the Innsbruck firm, Innovacell Biotechnologie AG, as the first patient was recruited at the MHAT Plovdiv clinic in Bulgaria for the Phase IIb study of the advanced therapy medicinal product, urocellĀ®. The clinical study will be conducted, beside Bulgaria, in the Czech Republic, Germany, Poland and Romania at more than 50 clinics.
An estimated 30% of adults experience insomnia, and a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons suggests that diet may be partly to blame.
Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2014. For the fourth quarter of 2014, Rigel reported a net loss of $22.3 million, or $0.25 per share, compared to a net loss of $16.9 million, or $0.19 per share, in the fourth quarter of 2013.
"I think it will not surprise you if I say that the immune system is one of our most important organ systems. Its relevance is obvious if only for the fact that it has been reinvented several times throughout the evolution of life," says Professor Andreas Radbruch, President of the German Society of Immunology and Director of the Deutsches Rheuma-Forschungszentrum, Berlin. He lectured about the miracle of our immune system at the Opening Press Conference of the 2nd European Congress of Immunology.
› Verified 3 days ago
Entity Name | Ihc Health Services Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1942325154 PECOS PAC ID: 1850209420 Enrollment ID: O20080610000303 |
News Archive
"First patient in" is the call from the Innsbruck firm, Innovacell Biotechnologie AG, as the first patient was recruited at the MHAT Plovdiv clinic in Bulgaria for the Phase IIb study of the advanced therapy medicinal product, urocellĀ®. The clinical study will be conducted, beside Bulgaria, in the Czech Republic, Germany, Poland and Romania at more than 50 clinics.
An estimated 30% of adults experience insomnia, and a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons suggests that diet may be partly to blame.
Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2014. For the fourth quarter of 2014, Rigel reported a net loss of $22.3 million, or $0.25 per share, compared to a net loss of $16.9 million, or $0.19 per share, in the fourth quarter of 2013.
"I think it will not surprise you if I say that the immune system is one of our most important organ systems. Its relevance is obvious if only for the fact that it has been reinvented several times throughout the evolution of life," says Professor Andreas Radbruch, President of the German Society of Immunology and Director of the Deutsches Rheuma-Forschungszentrum, Berlin. He lectured about the miracle of our immune system at the Opening Press Conference of the 2nd European Congress of Immunology.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Randy Gilliland, PHD 412 W 800 N, Orem, UT 84057-3728 Ph: (801) 235-7246 | Dr Randy Gilliland, PHD 525 W 200 N, Mona, UT 84648 Ph: (801) 375-4240 |
News Archive
"First patient in" is the call from the Innsbruck firm, Innovacell Biotechnologie AG, as the first patient was recruited at the MHAT Plovdiv clinic in Bulgaria for the Phase IIb study of the advanced therapy medicinal product, urocellĀ®. The clinical study will be conducted, beside Bulgaria, in the Czech Republic, Germany, Poland and Romania at more than 50 clinics.
An estimated 30% of adults experience insomnia, and a new study by researchers at Columbia University Vagelos College of Physicians and Surgeons suggests that diet may be partly to blame.
Rigel Pharmaceuticals, Inc. today reported financial results for the fourth quarter and year ended December 31, 2014. For the fourth quarter of 2014, Rigel reported a net loss of $22.3 million, or $0.25 per share, compared to a net loss of $16.9 million, or $0.19 per share, in the fourth quarter of 2013.
"I think it will not surprise you if I say that the immune system is one of our most important organ systems. Its relevance is obvious if only for the fact that it has been reinvented several times throughout the evolution of life," says Professor Andreas Radbruch, President of the German Society of Immunology and Director of the Deutsches Rheuma-Forschungszentrum, Berlin. He lectured about the miracle of our immune system at the Opening Press Conference of the 2nd European Congress of Immunology.
› Verified 3 days ago